Stay updated on IDA53 Clinical Trial

Sign up to get notified when there's something new on the IDA53 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IDA53 Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:55:40.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the introduction of a new clinical trial titled 'IDA53-FILOCLL09', which focuses on the safety and efficacy of combining ibrutinib and daratumumab for treating relapsed or refractory chronic lymphocytic leukemia (CLL) with TP53 dysfunction. Key collaborators and investigators have been named, and the revision number has been updated to v2.15.0.
    Difference
    46%
    Check dated 2025-04-16T15:10:49.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:38:00.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:43:55.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T14:33:36.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-18T12:48:24.000Z thumbnail image

Stay in the know with updates to IDA53 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IDA53 Clinical Trial page.